What ICH M3(R2): Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals requires
ICH M3(R2) sets the framework for nonclinical safety studies required to support human clinical trials and marketing authorisation…
This is a preview. The full record adds the complete summary, 8 workflow steps, 16 schema fields and 5 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: International Council for Harmonisation (ICH) · Version: 1.0.0 · Last updated:
Primary source: https://database.ich.org/sites/default/files/M3_R2__Guideline.pdf
SHA-256 integrity: 8d6d9608a0bdbde80f78590e02fca4388e0a5fdf820ab1b1b58f05016f7b2d00
Primary Citations — 5 traced to source
- ICH Harmonised Guideline M3(R2) Nonclinical Safety Studies, June 2009
- ICH S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/ich-m3-r2-nonclinical-safety-studies.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/ich-m3-r2-nonclinical-safety-studies.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/ich-m3-r2-nonclinical-safety-studies
- Back to registry: Browse all 10,102 compliance nodes